David W. Boyer insider trades
Open-market stock purchases and sales by David W. Boyer, Chief Corp. Affairs Officer at Neurocrine Biosciences Inc, from SEC Form 4 filings since Feb 7, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 14, 2026 | NBIX Neurocrine Biosciences Inc | Sold | $130K |
| Sep 11, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Sep 11, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $302K |
| May 26, 2026 | NBIX Neurocrine Biosciences Inc | Sold | $609K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $103K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $121K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $668K |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 13, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Feb 12, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $106K |
| Feb 12, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| Jan 31, 2026 | NBIX Neurocrine Biosciences Inc | Sold (not open market) | $162K |
| Jan 31, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
Companies traded
- NBIX Neurocrine Biosciences Inc: 29 sales, last Sep 14, 2026